Nearly ten years after the launch of the COMPPARE study at the UF Health Proton Therapy Institute, its insights are helping to define the future of prostate cancer treatment. In December 2017, COMPPARE’s Principal Investigator Nancy P. Mendenhall, MD,…
A new report from the COMPPARE study has been published in the International Journal of Radiation Oncology • Biology • Physics (the Red Journal). “Can Engagement Aid in Design and Accrual on Clinical Trials? Observations from COMPPARE – A Prospective Comparison of Outcomes with Proton and Photon Radiation…
Two-year findings were discussed at ASCO in Chicago on May 31, but assessing long-term comparative outcomes like disease control, late toxicity and secondary cancers will need longer follow-up.
When you volunteered for COMPPARE, you might have heard about something its PCD. But what does that mean for you, really?…
Our most critical insights will come years after treatment ends, as long-term follow-up is essential to understanding lasting effects and benefits.
Learn about the importance of the Primary Completion Date, an exciting alternative to MRIs for prostate cancer biopsies, and more. …
COMPPARE Principal Investigator Nancy Price Mendenhall, MD, FACR, FASTRO, was invited to speak at the sixth annual Biennial Science of Global Prostate Cancer Disparities in Black Men Conference, held virtually November 10-13, 2021. The Prostate Cancer Transatlantic Consortium launched the event in Jacksonville, FL in 2010. Funded by the National…
The latest edition of the COMPPARE CONNECTION is now online.
Dr. Nancy Mendenhall, COMPPARE Principal Investigator, and Charles Griggs, Minority Engagement Group Coordinator, have been invited to participate in the seventh annual meeting of the Patient-Centered Outcomes Research Institute (PCORI), to be held virtually in November. Dr. Mendenhall and Mr. Griggs will contribute as panelists in a session focused on…
On February 17, 2021, Cancer Connections, a UF Monthly Educational & Networking Meeting, presented “COMPPARE Clinical Trial: Protons vs Photons to Treat Prostate Cancer.” Dr. Nancy Mendenhall, M.D., FACR, FASTRO, COMPPARE Principal Investigator, provided an overview of the UF-led national ongoing prostate cancer clinical trial, highlighting the differences between between…
